A groundbreaking study published in Nature reveals a transformative enzyme that could revolutionize the production of ...

Researchers at the Max Planck Institute for Evolutionary Anthropology have addressed a longstanding challenge in CRISPR ...

The U.S. biostimulants market represents a transformative opportunity for agribusinesses positioned to capitalize.

The DNA polymerase market is poised for steady growth, with a projected CAGR of 6-8% over the forecast period, driven by ...

The global biotechnology market is set to witness a growth rate of 13-15% in the next 5 years. Advancements in genetic ...

The creator of CRISPR babies is flirting again with infamy, this time through a mysterious alliance with an Internet-savvy ...

Gene editing, once a theoretical ambition, has matured into a revolutionary frontier in biotechnology. Technologies like CRISPR-Cas9, TALENs, and Zinc Finger Nucleases (ZFNs) have unlocked ...

Investors interested in the Genomics and Synthetic Biology theme may consider adding these three stocks to their portfolio - Intellia Therapeutics (NTLA), uniQure (QURE) and Verve Therapeutics (VERV).

For centuries, yeast has been an essential ingredient in the production of wine and bread. Scientists are able to adjust ...

BURLINGAME, CA, UNITED STATES, May 20, 2025 /EINPresswire.com/ -- Biotechnology Market is estimated to be valued at USD 1,034.63 Bn in 2025 and is expected to reach USD 2,330.47 Bn in 2032, exhibiting ...

U.S. technology is set to “do very well” under the administration of President Trump, and one sector in particular, said Ark ...